Finanzierung wird Erweiterung des Produktportfolios des Unternehmens vorantreiben und kommerzielle Reichweite erweitern ein führender Anbieter von leicht zugänglichen und skalierbaren Lösungen für die Einzelzellsequenzierung, gab heute bekannt, dass das Unternehmen…
Mary Kay Inc. is the world’s leading direct-selling skin care and color cosmetics brand1 . The company and its sponsored foundations, including the Mary Kay Ash Foundation in the United States, continue to fund various research programs and…
Horus Pharma, an independent French company leading player in ophthalmology, strengthens its international presence with the signature of eight distribution agreements – covering Romania, Portugal, Croatia, Turkey, Algeria, Qatar, Ireland and…
Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO® (active ingredient: velagliflozin), marking a significant step for the treatment of feline diabetes…
The “U.S. Cleanroom Film And Bags Market Size, Share & Trends Analysis Report By Product (Bags, Pouches, Tape, Boxes, Films & Wraps), By Material, By End-use, By States, And Segment Forecasts,…
ventureLAB concluded its 3rd annual HardTech Summit on November 8 & 9 in partnership with York Region, bringing together 800 global leaders, founders, partners, innovators, government officials and regulators both virtually…
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today…
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on November 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase…
4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate’s phase 2b clinical trial. This board, composed of eminent international experts, will…
On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors necessary for the development…
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Tuesday, November 14, 2023, at 2 p.m.…
Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an…